TABLE 2.

Number of treatment‐emergent adverse events (n = 19) (definitely related, probably related, or possibly related to lorcaserin) grouped by System Organ Class and preferred term, for both groups of participants

Event (System Organ Class/preferred term)	Alcohol use disorder (n = 10)	Methamphetamine use disorder (n = 8)
Number of participants with ≥1 medication‐related adverse event	7	5
Gastrointestinal disorders
Diarrhea	0	1
Dry mouth	2	1
Lip dry	1	0
Nausea	0	1
General disorders and administration site conditions
Lethargy	3	0
Metabolism and nutrition disorders
Decreased appetite	3	1
Nervous system disorders
Dizziness	2	0
Headache	2	2